The phosphate regulating hormone fibroblast growth factor-23. (Q37771349)

22 August 2017

1 reference

title

The phosphate regulating hormone fibroblast growth factor-23. (English)

1 reference

22 August 2017

R Marsell

1

1 reference

PubMed ID

20618171

22 August 2017

K B Jonsson

series ordinal

2

1 reference

22 August 2017

1 October 2010

1 reference

22 August 2017

1 reference

22 August 2017

200

1 reference

22 August 2017

2

1 reference

22 August 2017

97-106

1 reference

Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23

22 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2010.02163.X

Therapeutic effects of anti-FGF23 antibodies in hypophosphatemic rickets/osteomalacia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2010.02163.X

Serum parathyroid hormone in X-linked hypophosphatemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2010.02163.X

Osteoprotegerin and its ligand: a new paradigm for regulation of osteoclastogenesis and bone resorption.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2010.02163.X

The autosomal dominant hypophosphatemic rickets R176Q mutation in fibroblast growth factor 23 resists proteolytic cleavage and enhances in vivo biological potency

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2010.02163.X

Targeted inactivation of Npt2 in mice leads to severe renal phosphate wasting, hypercalciuria, and skeletal abnormalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2010.02163.X

FGF23 is processed by proprotein convertases but not by PHEX.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2010.02163.X

An FGF23 missense mutation causes familial tumoral calcinosis with hyperphosphatemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2010.02163.X

Mineral metabolism, mortality, and morbidity in maintenance hemodialysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2010.02163.X

FGF-23 inhibits renal tubular phosphate transport and is a PHEX substrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2010.02163.X

Hypophosphatemia with elevations in serum fibroblast growth factor 23 in a child with Jansen's metaphyseal chondrodysplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2010.02163.X

Hyperphosphataemia as a cardiovascular risk factor -- how to manage the problem

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2010.02163.X

Familial tumoral calcinosis and the role of O-glycosylation in the maintenance of phosphate homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2010.02163.X

Initial FGF23-mediated signaling occurs in the distal convoluted tubule

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2010.02163.X

Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2010.02163.X

Bone as an endocrine organ.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2010.02163.X

The role of mutant UDP-N-acetyl-alpha-D-galactosamine-polypeptide N-acetylgalactosaminyltransferase 3 in regulating serum intact fibroblast growth factor 23 and matrix extracellular phosphoglycoprotein in heritable tumoral calcinosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2010.02163.X

FGF23 decreases renal NaPi-2a and NaPi-2c expression and induces hypophosphatemia in vivo predominantly via FGF receptor 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2010.02163.X

Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2010.02163.X

A gene (PEX) with homologies to endopeptidases is mutated in patients with X-linked hypophosphatemic rickets. The HYP Consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2010.02163.X

A homozygous missense mutation in human KLOTHO causes severe tumoral calcinosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2010.02163.X

Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2010.02163.X

Novel regulators of phosphate homeostasis and bone metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2010.02163.X

Convergence between bone and energy homeostases: leptin regulation of bone mass

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2010.02163.X

Fibroblast growth factor-23 regulates parathyroid hormone and 1alpha-hydroxylase expression in cultured bovine parathyroid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2010.02163.X

Mutation of the mouse klotho gene leads to a syndrome resembling ageing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2010.02163.X

Endocrine fibroblast growth factors as regulators of metabolic homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2010.02163.X

Regulation of fibroblast growth factor-23 signaling by klotho

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2010.02163.X

Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2010.02163.X

Transgenic mice expressing fibroblast growth factor 23 under the control of the alpha1(I) collagen promoter exhibit growth retardation, osteomalacia, and disturbed phosphate homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2010.02163.X

Endocrine regulation of energy metabolism by the skeleton

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2010.02163.X

The journey from vitamin D-resistant rickets to the regulation of renal phosphate transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2010.02163.X

Fibroblast growth factor 23 is a counter-regulatory phosphaturic hormone for vitamin D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2010.02163.X

Pathogenic role of Fgf23 in Dmp1-null mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2010.02163.X

Management of disturbances of calcium and phosphate metabolism in chronic renal insufficiency, with emphasis on the control of hyperphosphataemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2010.02163.X

DMP1 mutations in autosomal recessive hypophosphatemia implicate a bone matrix protein in the regulation of phosphate homeostasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2010.02163.X

Loss-of-function ENPP1 mutations cause both generalized arterial calcification of infancy and autosomal-recessive hypophosphatemic rickets

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2010.02163.X

Fibroblast growth factor-23 is associated with parathyroid hormone and renal function in a population-based cohort of elderly men

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2010.02163.X

Gene expression analysis of kidneys from transgenic mice expressing fibroblast growth factor-23.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2010.02163.X

Relationship between circulating FGF23 and total body atherosclerosis in the community

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2010.02163.X

Calcium and phosphate metabolism in tumoral calcinosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2010.02163.X

21 January 2018

Physiology. Sister act.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2010.02163.X

Receptor specificity of the fibroblast growth factor family

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2010.02163.X

Nephrolithiasis and osteoporosis associated with hypophosphatemia caused by mutations in the type 2a sodium-phosphate cotransporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2010.02163.X

The FGF23-Klotho axis: endocrine regulation of phosphate homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2010.02163.X

FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2010.02163.X

Developmental expression and tissue distribution of Phex protein: effect of the Hyp mutation and relationship to bone markers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2010.02163.X

Oncogenous osteomalacia. Review of the world literature of 42 cases and report of two new cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2010.02163.X

Intestinal npt2b plays a major role in phosphate absorption and homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2010.02163.X

Klotho protein protects against endothelial dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2010.02163.X

Serum 1,25-Dihydroxyvitamin D Levels in Normal Subjects and in Patients with Hereditary Rickets or Bone Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2010.02163.X

Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2010.02163.X

Mutant FGF-23 responsible for autosomal dominant hypophosphatemic rickets is resistant to proteolytic cleavage and causes hypophosphatemia in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2010.02163.X

Vitamin D receptor-independent FGF23 actions in regulating phosphate and vitamin D metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2010.02163.X

Phosphate and the parathyroid

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2010.02163.X

Homozygous ablation of fibroblast growth factor-23 results in hyperphosphatemia and impaired skeletogenesis, and reverses hypophosphatemia in Phex-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2010.02163.X

Genetic ablation of vitamin D activation pathway reverses biochemical and skeletal anomalies in Fgf-23-null animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2010.02163.X

The direct role of vitamin D on bone homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2010.02163.X

Role of fibroblast growth factor 23 in phosphate homeostasis and pathogenesis of disordered mineral metabolism in chronic kidney disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2010.02163.X

Sinoatrial node dysfunction and early unexpected death of mice with a defect of klotho gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2010.02163.X

Phosphate transport: molecular basis, regulation and pathophysiology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2010.02163.X

Differential effects of Npt2a gene ablation and X-linked Hyp mutation on renal expression of Npt2c

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2010.02163.X

Mutations in GALNT3, encoding a protein involved in O-linked glycosylation, cause familial tumoral calcinosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2010.02163.X

Klotho converts canonical FGF receptor into a specific receptor for FGF23

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2010.02163.X

Phosphate transporters: a tale of two solute carrier families.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2010.02163.X

What goes in must come out--the small intestine modulates renal phosphate excretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2010.02163.X

Autosomal-dominant hypophosphatemic rickets (ADHR) mutations stabilize FGF-23

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2010.02163.X

The Autosomal Dominant Hypophosphatemic Rickets (ADHR) Gene Is a Secreted Polypeptide Overexpressed by Tumors that Cause Phosphate Wasting

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2010.02163.X

Identification of a novel fibroblast growth factor, FGF-23, preferentially expressed in the ventrolateral thalamic nucleus of the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2010.02163.X

Fibroblast growth factor (FGF)-23 inhibits renal phosphate reabsorption by activation of the mitogen-activated protein kinase pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2010.02163.X

Analysis of the biochemical mechanisms for the endocrine actions of fibroblast growth factor-23

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-1716.2010.02163.X

10.1111/J.1748-1716.2010.02163.X

21 January 2018

Identifiers

DOI

1 reference

22 August 2017

1 reference

PubMed ID

20618171